Axa
GHDX

Axa’s Genomic Health, Inc. GHDX Stock Holding History

Axa’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,400
Closed -$314K – 1383
2019
Q2 		$314K Sell
5,400
-83,300
-94% -$4.93M ﹤0.01% 1154
2019
Q1 		$6.21M Buy
88,700
+6,200
+8% +$460K 0.02% 579
2018
Q4 		$5.31M Buy
+82,500
New +$5.78M 0.02% 588
2014
Q1 		– Sell
-9,546
Closed -$279K – 1488
2013
Q4 		$279K Sell
9,546
-4,100
-30% -$130K ﹤0.01% 1166
2013
Q3 		$417K Hold
13,646
– – ﹤0.01% 1036
2013
Q2 		$433K Buy
+13,646
New +$448K ﹤0.01% 994

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Axa's GHDX Position: Q3 2019 in Review

Axa sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 5,400 shares — an estimated $314K sold.

Axa first reported a position in GHDX in Q2 2013 and held it in 6 quarters. The position peaked at $6.21M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Axa reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Axa sold 5,400 Genomic Health, Inc. shares in Q3 2019, an estimated $314K.
  • Axa first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 6 quarters.
  • Axa's Genomic Health, Inc. position peaked at $6.21M in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Axa's 13F filing for Q3 2019, filed 14 Nov 2019.